The tailor-made double-wall VIP insulated shipper provides 10+ days of temperature protection for vaccine shipments from BioNTech’s facility with minimal dry ice.
DAYTON, Ohio, May 5, 2021 – CSafe Global, the innovation leader in active, passive parcel and cell and gene temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals is honored to partner with BioNTech as the thermal shipping solution provider for Pfizer-BioNTech COVID-19 Vaccine shipments from BioNTech’s facility in Germany. The custom thermal shipping container maintains -70°C for a minimum of 240 hours to help ensure the vaccine arrives safely at locations around the world.
The custom container uses a double wall of best-in-class Vacuum Insulated Panel (VIP) technology, a custom payload box with product vial trays with a built-in handle for simplified packing and unpacking. Thermal testing exceeded all expectations and the shipper consistently performed well beyond the 240-hour minimum. The container will maintain the desired temperature indefinitely with the addition of dry ice as needed.
“Using innovative engineering design concepts, the CSafe team was able to exceed BioNTech’s requirements for a high-performance container that will maintain -70°C for more than 10 days,” said Patrick Schafer, CSafe Global CEO. “Additionally, we were also able to reduce the amount of dry ice needed by more than 30% from our original projection by making additional tweaks to the design. CSafe has always been a purpose-driven company and every one of our employees couldn’t be prouder of this tremendous achievement and our role in helping BioNTech put an end to the pandemic.”
The Pfizer-BioNTech COVID-19 Vaccine (BNT162b2), which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States (jointly with Pfizer), United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.
CSafe Global continues to focus on innovating temperature-controlled container solutions with the launch of 24/7 real-time shipment visibility.
DAYTON, Ohio, Dec. 1, 2020 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced today the full commercial launch of the company’s real-time shipment visibility platform and technology that will give CSafe customers the opportunity to make data-driven decisions to ensure the safe delivery of medicines to patients worldwide.
Available now to CSafe air cargo customers, the company has already started retrofitting active RKN and RAP containers with the new sensors capable of tracking location and condition. The platform, custom built by Cloudleaf, Inc. in close collaboration with CSafe operations, provides real-time alerts and notifications directly to customers via email, text or in the platform itself of the following for each shipment:
- Cargo temperature outside set parameters
- Door open events
- Ambient temperature change outside set parameters
- Shock event
- Tilt event
- Ambient pressure change outside set parameters
- Ambient humidity change outside set parameters
- Route deviation / delay
CSafe customers who take advantage of the new platform will also benefit from many other features included with every lease such as:
- Request and manage leases
- Add an unlimited number of platform users
- Monitor all shipments in real-time
- Customize real-time alerts and notifications
- Customize locations for routes and save for future shipments
- Access historical shipments
- Export data in real-time during the shipment to intervene as needed
- Receive GDP compliant standard shipment report
- Use standard rest API packet
“I am beyond proud of the teams of people who have worked tirelessly on this project for more than two years to deliver so much more than just basic functionality to our customers,” said Patrick Schafer, CSafe CEO. “What we have built in partnership with Cloudleaf is a system that is fit for our customers’ needs today and agile enough to easily accommodate enhancements and new innovations well into the future.”
Tom Weir, CSafe COO, who has led the effort from the beginning, noted that, “the entire team is excited about today’s official launch, but that doesn’t mean the work is over. We will be retrofitting the remainder of the active container fleet throughout Q1 before we move on to our roadmap of enhancements. We’ll also be bringing our Cell & Gene customers onto the platform and implementing the system for VIP Parcel containers and customers to offer the capability across our entire product portfolio.”
Weir noted that CSafe has received FAA approval for the tracking device integration into both the CSafe RKN and CSafe RAP active containers.
CSafe Global has expanded its Life Science sales team in Europe by adding new team members in The Netherlands and Italy.
DAYTON, Ohio, July 28, 2020 — CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has been rapidly expanding the life science sales team throughout Europe to support a growing customer base.
CSafe has been building its worldwide Life Science sales team more than a year to better serve customers in local markets. “As of this month, we have sales directors in key countries to serve local pharmaceutical and life science companies,” said Stephen Kay, CSafe Global’s senior director of life sciences – Europe. “Europe has always been at the forefront of the pharmaceutical market and building an exceptional team of people who understand both the industry and the culture in each country is key to providing the service level CSafe is known for.”
The newest additions to the team include Vincenzo Cuffaro and Gidius van den Eng.
Cuffaro brings seven years’ experience logistics and the healthcare and pharmaceutical industries in Italy and across EMEA. Most recently, he was a Key Account Manager for Pharma & Healthcare for Kuehne + Nagel managing customers on a national, regional or global level. In his new role as Director of Life Science Sales, he will support customers in the south of Europe providing key expertise to help them find the best temperature-controlled air cargo solutions for their needs.
Van den Eng has been working in international logistics and supply chain management for nearly a decade specializing in the life sciences industry. He joins CSafe following seven years with DSV Panalpina A / S (formerly Panalpina) as a Key Account Manager managing multiple global healthcare accounts across the EMEA region. As Director of Passive Life Science Sales – Europe, he will support CSafe customers across the continent with all of their needs for thermal shippers and couriers as well as mobile refrigeration / freezer requirements.
“Europe is a critical market for pharmaceuticals and biologics and CSafe is committed to providing the local support customers need,” said CSafe Chief Commercial Officer, Seth Hertel. These two additions to our existing European team members in the United Kingdom and Ireland, DACH region, France, Benelux and Scandinavia ensure CSafe has the ability to meet the demand for our full suite of air cargo and parcel solutions throughout the region. We are thrilled to them on board and confident they will exceed our expectations.”